Company Overview of Target Discovery, Inc.
Target Discovery, Inc. discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and management of disease. The company focuses on isoforms protein biomarkers and diagnostics for cancer. It develops and commercializes Isonostic products that include Isonostic assays for the monitoring and treatment of prostate, breast, and ovarian cancer. Target Discovery, Inc. was founded in 1999 and is headquartered in Palo Alto, California.
4030 Fabian Way
Palo Alto, CA 94303-4607
Founded in 1999
Key Executives for Target Discovery, Inc.
Similar Private Companies By Industry
|Technologene Inc.||United States|
|Genentech USA, Inc.||United States|
|RoosterBio, Inc.||United States|
|Eleison Pharmaceuticals Inc.||United States|
|RGene Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Target Discovery, Inc., please visit www.targetdiscovery.com. Company data is provided by Capital IQ. Please use this form to report any data issues.